Author

G. Sflomos

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 3 Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Organism:human· 1

Frequent Co-Authors

C. Brisken· 3 shared A. Ayyanan· 1 shared A. Basudan· 1 shared A. Elangovan· 1 shared A. Patrik· 1 shared A. Stravodimou· 1 shared A. Treboux· 1 shared Adrian V Lee· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

C. Brisken

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

WCRC-25: A novel luminal Invasive Lobular Carcinoma cell line model

A. Elangovan, E. A. Bossart, A. Basudan, N. Tasdemir, O. S. Shah, K. Ding, S. C. Purdy, C. Meier, T. Heim, C. Neumann, S. Attaran, L. Brown, J. Hooda, L. Miller, K. Kota, , S. Oesterreich

The paper introduces a new invasive lobular carcinoma cell line, WCRC-25, and demonstrates its molecular features and therapeutic response to PI3K/AKT inhibition.

bioRxiv · Sep 15, 2023 · PreprintCancer Biology

Epithelial-mesenchymal plasticity determines estrogen receptor positive (ER+) breast cancer dormancy and reacquisition of an epithelial state drives awakening

A. Patrik, Z. Yueyun, C. Stibolt, M. Sendurai, G. Sflomos, C. Brisken

This study shows that epithelial-mesenchymal plasticity enables dormancy in ER+ breast cancer and reacquiring an epithelial state promotes awakening.

bioRxiv · Jul 22, 2021Cancer Biology

Intraductal patient derived xenografts of estrogen receptor positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesions

C. Brisken, M. Fiche, G. Sflomos, A. Treboux, A. Stravodimou, V. Scabia, A. Ayyanan, Reseau Lausannois du Sein, K. Zaman, L. Battista

The paper establishes that intraductal patient-derived xenografts (ID-PDXs) of ER+ breast cancer replicate histopathological features and metastatic potential, suggesting early tumor dissemination.

bioRxiv · Sep 11, 2018Cancer Biology